Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Respir Med ; 218: 107368, 2023 11.
Artículo en Inglés | MEDLINE | ID: mdl-37562659

RESUMEN

OBJECTIVE: Incorrect inhaler use and poor treatment adherence have a negative impact on COPD outcomes. This multi-centre, single arm, non-interventional, phase IV study investigated whether inhalation technique, treatment adherence and patient outcomes change in patients who evolve from dual therapy or multiple inhaler triple therapy to single inhaler extrafine triple therapy (beclomethasone dipropionate (BDP, 87 µg), formoterol fumarate (FF, 5 µg) and glycopyrronium (G, 9 µg)) in combination with inhalation technique training. METHODS: A total of 126 COPD patients were included in the per protocol set. Inhalation technique and treatment adherence were assessed at baseline and at two visits at approximately 3 and 6 months of treatment with extrafine BDP/FF/G. In addition, lung function, symptom score, patient satisfaction and exacerbations (exploratory) were followed up. RESULTS: Before switching to single inhaler extrafine BDP/FF/G (baseline), any device errors and critical errors were detected for 28.8% and 9.6% of patients, respectively. After switching to BDP/FF/G, the percentage of patients with any device errors decreased to 14.0% (visit 2) and 16.3% (visit 3), without critical errors at the two follow-up visits. Treatment adherence increased from 67.5% at baseline to 75.8% (visit 2) and 80% (visit 3). In addition, lung function, symptom and patient satisfaction scores improved, whilst exacerbation rates substantially decreased. CONCLUSIONS: This observational study demonstrates that in eligible COPD patients in a real-life setting, the switch from dual therapy or multiple inhaler triple therapy to single inhaler extrafine BDP/FF/G in combination with inhalation technique training is associated with improved inhalation technique and adherence.


Asunto(s)
Enfermedad Pulmonar Obstructiva Crónica , Humanos , Administración por Inhalación , Resultado del Tratamiento , Fumarato de Formoterol , Beclometasona , Nebulizadores y Vaporizadores , Atención al Paciente , Combinación de Medicamentos
2.
Rev Mal Respir ; 36(1): 118-120, 2019 01.
Artículo en Francés | MEDLINE | ID: mdl-30098878
3.
Acta Chir Belg ; 115(3): 234-6, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26158258

RESUMEN

Lung expansion after pneumonectomy is well documented in animal models like dogs or mice. We present a lung expansion case after left pneumonectomy for an advanced carcinoid tumor in a 16-year-old patient with hemoptysis and acute dyspnea. This tumor was localized in the left upper lobe (LUL) invading the left main bronchus. During the follow-up we noticed a real growth of the remaining lung.


Asunto(s)
Tumor Carcinoide/cirugía , Neoplasias Pulmonares/cirugía , Pulmón/crecimiento & desarrollo , Neumonectomía , Adolescente , Femenino , Humanos , Mediciones del Volumen Pulmonar , Tamaño de los Órganos , Periodo Posoperatorio
6.
Ann Emerg Med ; 20(1): 93-4, 1991 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1984739

RESUMEN

A previously healthy 47-year-old woman presented to the emergency department with septic shock five days after a small dog bite on the dorsum of her hand. Capnocytophaga canimorsus was isolated from blood cultures. Despite intensive therapy, multiple organ failure developed, and the patient died 27 days after admission. Characteristics of Capnocytophaga (formerly CDC group Dysgonic Fermenter-2) infection are briefly discussed. This unusual outcome in a previously healthy patient and the need for careful management of dog bite wounds, even if initially very small, is emphasized.


Asunto(s)
Mordeduras y Picaduras/complicaciones , Capnocytophaga/patogenicidad , Perros/microbiología , Sepsis/microbiología , Animales , Capnocytophaga/aislamiento & purificación , Femenino , Humanos , Persona de Mediana Edad , Sepsis/transmisión
7.
Intensive Care Med ; 16(7): 460-2, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2269716

RESUMEN

A particularly severe case of Guillain-Barré syndrome occurring during pregnancy is reported. The therapeutic approach including plasmapheresis, ventilation, analgesia, sedation, metabolic requirements and heparin therapy is discussed with the consequences on foetal development and the early days of life.


Asunto(s)
Cuidados Críticos , Polirradiculoneuropatía/terapia , Complicaciones del Embarazo/terapia , Adulto , Cesárea , Femenino , Humanos , Recién Nacido , Polirradiculoneuropatía/complicaciones , Embarazo , Cuadriplejía/etiología , Cuadriplejía/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...